269 related articles for article (PubMed ID: 28489582)
21. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.
Yin QH; Liu C; Hu JB; Meng RR; Li L; Wang YJ
Asian Pac J Cancer Prev; 2013; 14(1):231-6. PubMed ID: 23534729
[TBL] [Abstract][Full Text] [Related]
22. Associations between XPD Asp312Asn polymorphism and risk of head and neck cancer: a meta-analysis based on 7,122 subjects.
Hu YY; Yuan H; Jiang GB; Chen N; Wen L; Leng WD; Zeng XT; Niu YM
PLoS One; 2012; 7(4):e35220. PubMed ID: 22536360
[TBL] [Abstract][Full Text] [Related]
23. Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis.
Duan XL; Gong H; Zeng XT; Ni XB; Yan Y; Chen W; Liu GL
Asian Pac J Cancer Prev; 2012; 13(7):3299-303. PubMed ID: 22994751
[TBL] [Abstract][Full Text] [Related]
24. Genetic variants of DNA repair pathway genes on lung cancer risk.
Li W; Zhang M; Huang C; Meng J; Yin X; Sun G
Pathol Res Pract; 2019 Oct; 215(10):152548. PubMed ID: 31337555
[TBL] [Abstract][Full Text] [Related]
25. Association between ERCC2 Lys751Gln polymorphism and the risk of pancreatic cancer, especially among Asians: evidence from a meta-analysis.
Wu Y; Lu ZP; Zhang JJ; Liu DF; Shi GD; Zhang C; Qin ZQ; Zhang JZ; He Y; Wu PF; Miao Y; Jiang KR
Oncotarget; 2017 Jul; 8(30):50124-50132. PubMed ID: 28223548
[TBL] [Abstract][Full Text] [Related]
26. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
Zhou CX; Zhao JH
Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
[TBL] [Abstract][Full Text] [Related]
27. XPD Asp312Asn polymorphism is a risk factor for prostate cancer.
Liao SG; Liu L; Wang Y; Zhang YY; Wang YJ
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1689-95. PubMed ID: 22644997
[TBL] [Abstract][Full Text] [Related]
28. Excision repair cross-complementing group 2/Xeroderma pigmentousm complementation group D (ERCC2/XPD) genetic variations and susceptibility to diffuse large B cell lymphoma in Egypt.
El-Din MA; Khorshied MM; El-Saadany ZA; El-Banna MA; Reda Khorshid OM
Int J Hematol; 2013 Dec; 98(6):681-6. PubMed ID: 24258710
[TBL] [Abstract][Full Text] [Related]
29. XPD Lys751Gln and Asp312Asn polymorphisms and susceptibility to skin cancer: a meta-analysis of 17 case-control studies.
Zhu HL; Bao JM; Lin PX; Li WX; Zou ZN; Huang YE; Chen Q; Shen H
Asian Pac J Cancer Prev; 2014; 15(16):6619-25. PubMed ID: 25169498
[TBL] [Abstract][Full Text] [Related]
30. Association between polymorphisms in ERCC2 gene and oral cancer risk: evidence from a meta-analysis.
Zhang E; Cui Z; Xu Z; Duan W; Huang S; Tan X; Yin Z; Sun C; Lu L
BMC Cancer; 2013 Dec; 13():594. PubMed ID: 24330540
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India.
Srivastava K; Srivastava A; Mittal B
Cancer; 2010 Jul; 116(13):3160-9. PubMed ID: 20564624
[TBL] [Abstract][Full Text] [Related]
32. Association of R156R single nucleotide polymorphism of the ERCC2 gene with the susceptibility to ovarian cancer.
Romanowicz H; Michalska MM; Samulak D; Malinowski J; Szaflik T; Bieńkiewicz J; Smolarz B
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():36-40. PubMed ID: 27888704
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
[TBL] [Abstract][Full Text] [Related]
34. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.
Yuan H; Niu YM; Wang RX; Li HZ; Chen N
Genet Mol Res; 2011 Nov; 10(4):3356-64. PubMed ID: 22179996
[TBL] [Abstract][Full Text] [Related]
35. Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.
Li SX; Dai QS; Chen SX; Zhang SD; Liao XY; Deng X; Chi HB; Li FJ; Zhu JH; Jiang YY
Tumour Biol; 2014 Apr; 35(4):3905-15. PubMed ID: 24347488
[TBL] [Abstract][Full Text] [Related]
36. DNA repair pathway genes and lung cancer susceptibility: a meta-analysis.
Li W; Li K; Zhao L; Zou H
Gene; 2014 Apr; 538(2):361-5. PubMed ID: 24368330
[TBL] [Abstract][Full Text] [Related]
37. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
38. ERCC2 polymorphisms and radiation-induced adverse effects on normal tissue: systematic review with meta-analysis and trial sequential analysis.
Song YZ; Duan MN; Zhang YY; Shi WY; Xia CC; Dong LH
Radiat Oncol; 2015 Dec; 10():247. PubMed ID: 26627042
[TBL] [Abstract][Full Text] [Related]
39. Single nucleotide polymorphisms in DNA repair genes and the risk of laryngeal cancer: A meta-analysis.
Li F; Wang J; Chen M
Biomed Pharmacother; 2016 Mar; 78():92-100. PubMed ID: 26898429
[TBL] [Abstract][Full Text] [Related]
40. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Res; 2002 Mar; 62(5):1377-81. PubMed ID: 11888908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
